Source:http://linkedlifedata.com/resource/pubmed/id/19998807
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2009-12-11
|
pubmed:abstractText |
Cardiac resynchronization therapy (CRT) is a novel treatment for systolic heart failure and in successful cases reverse remodeling occurs with reduction of left ventricular (LV) dimensions and volumes. The term "responders" applies to all patients who improve in functional class and quality of life; however, some responders show exceptional improvement, including normalization of clinical and echocardiographic parameters (exceptional or super-responders).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0870-2551
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
959-69
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Cardiac resynchronization therapy--clinical and echocardiographic characteristics of responders and exceptional responders.
|
pubmed:affiliation |
Laboratório de Ecocardiografia, Serviço de Cardiologia, Hospital Santa Marta, Lisboa, Portugal. anagalrinho@spc.pt
|
pubmed:publicationType |
Journal Article
|